 | Articles: Drug/Product Alerts |

Tetracycline Therapy: Update
Clinical Infectious Diseases, 01/29/03
Recent changes to FDA-approved labeling
American Journal of Health-System Pharmacy, 01/27/03
Paracetamol-induced hepatotoxicity at recommended dosage
Journal of Internal Medicine, 01/27/03
|
| | Sponsor |
FDA Alert: Study of asthma-drug halted
Center for Drug Evaluation and Research, 01/24/03
Rx Perspective: Unique Mydriatic Returns
Ophthalmology Management, 01/21/03
Risk of serious skin disorders among users of oral antifungals: a population-based study
BMC Dermatology, 01/20/03
Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?
Cleveland Clinic Journal of Medicine, 01/10/03
Reporting of adverse drug reactions in randomised controlled trials: a systematic survey
BMC Clinical Pharmacology, 01/09/03
FDA Approves New Labels for Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women Following Review of Womens Health Initiative Data
FDA Press Releases , 01/09/03
Dead Bugs Don't Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance
Emerging Infectious Diseases, 12/26/02
|
Receive daily email updates on Drug/Product Alerts
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
110 Available Pages
 |
 |
| Read a Different Specialty |
 |
|
|
|
 |
| Profession Index |
 |
|
|
|
 |
|
|